PRECISION TARGETING OF CELL CYCLE CHECKPOINTS IN TP53-MUTANT ENDOMETRIAL CANCER.

$2,222,168FY2022Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

PRECISION TARGETING OF CELL CYCLE CHECKPOINTS IN TP53-MUTANT ENDOMETRIAL CANCER. · GrantIndex